S.A. Team

About the Author S.A. Team

Smarter Analyst was established to fill a gap in financial reporting for sell-side investors, where they can read exclusive reports in real time. Smarter Analyst provides coverage of equities research, unique analyst insights, and outstanding articles from knowledgeable contributors, in addition to the latest stock market news, all hand-picked by our editors.

After Teva Pharmaceutical’s Big Jump, This Analyst Remains Unenthused

Cost cutting is great, but the benefits have been quickly priced into the stock.

Read more

If Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Looks Cheap, It May Be Cheap for a Reason

Should you pull the trigger on Teva? Guggenheim’s Rohit Vanjani is fine staying sidelined.

Read more

Trading Cable Heading into the New Year

The GBP/USD currency pair is holding at the critical 1.34 level. The cable has a …

Read more

Veeva Systems Is Worth the Buy Longer-Term, Says Canaccord

While Veeva Systems (NYSE:VEEV) shares are dipping close to 7% after a print that failed …

Read more

This Analyst Finds Nutanix Well-Positioned in the Enterprise Market Following Raymond James Tech Conference

After Nutanix Inc (NASDAQ:NTNX) CFO Duston Williams discussed the company’s transition to software taking center …

Read more

Does Helios and Matheson Analytics’ Selloff Represents a Buying Opportunity?

Helios and Matheson Analytics (NASDAQ:HMNY) is an IT consulting company — but one with a …

Read more

Does This Analyst Make a Good Case for Matheson Analytics Inc (HMNY)?

For much of its lifetime as a public company, the stock chart of IT consulting …

Read more

Guggenheim Storms Into the Dermatology Space; Initiates Buy on Revance Therapeutics, Inc. (RVNC)

Guggenheim analyst Rohit Vanjani has initiated coverage of the dermatology space, announcing ratings on four …

Read more

Raymond James Sings the Praises of Adamis Pharmaceuticals; Here’s Why

What does the future hold for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)? Raymond James analyst Elliot Wilbur …

Read more

Investing Guru Jim Simons Rolls Out the Red Carpet for Valeant Pharmaceuticals, Cuts Opko Health

Jim Simons, the founder of one of the world’s most successful hedge funds, is splashing …

Read more